Medical Condition News

RSS
Temozolomide and radiation combination improves survival in low-grade glioma patients

Temozolomide and radiation combination improves survival in low-grade glioma patients

Study highlights barriers to long-term recovery for opioid use disorder patients

Study highlights barriers to long-term recovery for opioid use disorder patients

Knowing your family health history is key to reducing heart attack or stroke risk

Knowing your family health history is key to reducing heart attack or stroke risk

Targeted intervention substantially boosts colorectal cancer screening rates

Targeted intervention substantially boosts colorectal cancer screening rates

Wearable electrical nerve stimulation device can reduce pain and fatigue linked to long COVID

Wearable electrical nerve stimulation device can reduce pain and fatigue linked to long COVID

Brain volume loss linked to Alzheimer's treatment may be caused by amyloid plaque removal

Brain volume loss linked to Alzheimer's treatment may be caused by amyloid plaque removal

Robust measures developed to study how social determinants influence spinal cord injury outcomes

Robust measures developed to study how social determinants influence spinal cord injury outcomes

IASLC and LCRF announce first grant recipient for lung cancer research

IASLC and LCRF announce first grant recipient for lung cancer research

ASTRO releases updated guidelines for treating locally advanced rectal cancer

ASTRO releases updated guidelines for treating locally advanced rectal cancer

History of endometriosis and fibroids linked to higher long-term risk of early death

History of endometriosis and fibroids linked to higher long-term risk of early death

New study offers insights into reliable Alzheimer's diagnosis

New study offers insights into reliable Alzheimer's diagnosis

Steritas announces collaboration with argenx to advance evidence for novel steroid-sparing therapeutics

Steritas announces collaboration with argenx to advance evidence for novel steroid-sparing therapeutics

Groundbreaking research sheds light on mitochondrial DNA depletion syndrome

Groundbreaking research sheds light on mitochondrial DNA depletion syndrome

Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line

Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line

Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosis

Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosis

Mursla Bio's EvoLiver surpasses current standards in liver cancer surveillance, data presented at AASLD Liver Meeting 2024

Mursla Bio's EvoLiver surpasses current standards in liver cancer surveillance, data presented at AASLD Liver Meeting 2024

Study points to a strategy for inhibiting hyper-progression of melanoma

Study points to a strategy for inhibiting hyper-progression of melanoma

Mursla Bio announces promising results for EvoLiver test in liver cancer detection

Mursla Bio announces promising results for EvoLiver test in liver cancer detection

Study shows growing cancer treatment inequities between high and low-income countries

Study shows growing cancer treatment inequities between high and low-income countries

Could medical imaging innovation be the catalyst for precision medicine?

Could medical imaging innovation be the catalyst for precision medicine?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.